Exencial Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History
Exencial Wealth Advisors, LLC
- $2.63 Billion
- Q1 2025
A detailed history of Exencial Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 16,004 shares of BMY stock, worth $748,187. This represents 0.04% of its overall portfolio holdings.
Number of Shares
16,004
Previous 16,776
4.6%
Holding current value
$748,187
Previous $948,000
2.95%
% of portfolio
0.04%
Previous 0.04%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,801Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.95 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.42 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.05 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.43 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...